Dataset Information


Search for specific biomarkers of IFN-beta bioactivity in patients with MS

ABSTRACT: We aimed to identify specific biomarkers of IFN-beta bioactivity in order to compare their gene expression induction by type I IFNs with the MxA, and to investigate their potential role in MS pathogenesis. Gene expression microarrays were performed in PBMC from MS patients who developed neutralizing antibodies (NAB) to IFN-beta. Nine genes followed patterns in gene expression over time similar to the MX1 and were selected for further experiments: IFI6, IFI27, IFI44L, IFIT1, HERC5, LY6E, RSAD2, SIGLEC1, and USP18. In vitro experiments revealed specific induction of selected biomarkers by IFN-beta but not IFN-gamma, and several markers, in particular USP18 and HERC5, were significantly induced at lower IFN-beta concentrations and more selective than the MX1 as biomarkers of IFN-beta bioactivity. In addition, USP18 expression was deficient in MS patients compared with healthy controls (p=0.0004). We propose specific biomarkers that may be considered in addition to the MxA to evaluate IFN-beta bioactivity, and to further explore their implication in MS pathogenesis. Overall design: Number of samples: 32. We analyzed PBMC from 8 patients at baseline and after 3, 12 and 24 months of IFN-beta treatment

INSTRUMENT(S): [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array

ORGANISM(S): Homo sapiens  

SUBMITTER: Ramil Nurtdinov  

PROVIDER: GSE26104 | GEO | 2010-12-18



Similar Datasets

2010-12-18 | E-GEOD-26104 | ArrayExpress
| PRJNA135181 | ENA
| GSE77676 | GEO
2015-04-20 | E-GEOD-61500 | ArrayExpress
2015-04-20 | E-GEOD-61499 | ArrayExpress
2006-08-23 | GSE5574 | GEO
| GSE99858 | GEO
2015-05-02 | E-GEOD-37750 | ArrayExpress
2014-07-30 | E-GEOD-58240 | ArrayExpress
2008-10-30 | GSE8802 | GEO